Individual decision · SEC · 9 Jan 2019

SEC Division of Investment Management staff letter: Tekla Life Sciences Investors - Omission of Shareholder Proposal Submitted by Kenneth Steiner

2 files · 12 PDF pages

The staff of the Division of Investment Management will not recommend enforcement action if Tekla Life Sciences Investors excludes a shareholder proposal from its 2019 proxy materials, provided the proponent revises the proposal to clarify that it will not affect the unexpired terms of directors elected prior to implementation. The staff cannot assure the Fund that exclusion is permissible under Rule 14a-8(i)(3) regarding materially false or misleading statements, as the Fund failed to demonstrate that the supporting statement was objectively false. The Fund must receive the revised proposal within seven calendar days of the letter to qualify for this no-action assurance.

US FederalSecurities and Exchange Commission
Enclosure 1 of 1 · 12 pages · PDF 3.1 MBRegulator's file ↗

Incoming Letter

Annotations and obligations
15 obligations · 5 permissions · 27 definitions · 2 reporting items
  1. Main text
  2. Incoming Letter
  • Obligation 15
  • Permission 5
  • Definition / condition 27
  • Reporting template 2
  • background, boilerplate

More like this from SEC

SEC published 7 documents in the last 30 days. We email you each new one the day it's published.

Source: Securities and Exchange Commission — original document · Summary generated with machine assistance and reviewed before publication; the authoritative text is the regulator's original document. How RegAlert works

In RegAlert: added · updated